As the field of interventional cardiology continues to evolve, innovations in imaging and stent-free treatment methods are ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone, and welcome to the InspireMD Third Quarter ...

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery disease (PAD). Solaris Endovascular develops evidence-based technologies, ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

InspireMD Inc., a Delaware-based medical device company, focuses on the development and commercialization of its proprietary MicroNet™ stent platform technology, which is used in the treatment of ...

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

Two men enrolled under a central government health scheme, who died soon after angioplasty was performed on them at a private hospital in Ahmedabad, did not require the heart procedure, a top Gujarat ...

A heart attack occurs when some part of the heart muscle stops receiving enough oxygenated blood to stay alive ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

On World Heart Day, Dr. Praveen Chandra highlights the dangers of cardiovascular diseases beyond heart attacks.